Team: No. 16 Drive Down A1C Lilly Diabetes Ford Mustang
Crew Chief: Phil Gould
Twitter: @driverRyanReed, @Reed16Team and @RoushFenway
ADVANCE NOTES
Reed at Dover
This weekend’s NASCAR Xfinity Series race at Dover International Speedway marks Ryan Reed’s 10th start at the Monster Mile. In his nine previous starts, Reed has one top-five and two top-10 finishes. His best finish of fifth came in the 2017 spring race.
Dover 2018
Ryan Reed was running 15th and chasing down the next pack in front of him when contact from another competitor sent him into the turn two wall. Multiple pit stops for repairs ensued, but Reed was able to stay on the lead lap to cross the finish line 19th in his No. 16 Drive Down A1C Lilly Diabetes Ford.
Reed on Dover
“We had a top five last year and that was by far my best Dover race. Dover has been a track that I’ve struggled at in the past and we struggled there at the beginning of this year. The good news is we have a top five there, we know that we can do it. I know as a driver I can do it. We just have to go to work and really figure out our setup for that place. We are heading in the right direction. We’re seeing what Matt, Ricky and Trevor are doing on the Cup side to get better, we need to keep using all that information throughout our organization. Dover is a place we have the opportunity to run good, but if we don’t make the right decisions we can go run 13th or 14th and not be in the Playoffs after that, so there is a lot of pressure. I’ve been a part of a few of these cutoff races and they are so intense, so much pressure. We just have to go there and execute.”
www.DriveDownA1C.com
Ryan Reed and Lilly Diabetes are encouraging and motivating NASCAR fans to better manage their diabetes by visiting www.DriveDownA1C.com to learn more about resources and treatment options.
Did You Know?
Ryan Reed was diagnosed at the age of 17 with Type 1 Diabetes. Through hard work, perseverance and working with his doctors he’s been able to manage his diabetes and set an example to others.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes. We offer a wide range of therapies and a continued determination to provide real solutions—from medicines and technologies to support programs and more. For the latest updates, visit http://www.lillydiabetes.com/ or follow us on Twitter: @LillyDiabetes and Facebook: LillyDiabetesUS.
